Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Johnson & Johnson (JNJ)

  • Business News
  • Jan. 13, 2026, 13:03 UTC
  • 6
  • 1 comments

Johnson & Johnson - Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting

Market reaction Comment Full text

Natera Inc (NTRA)

  • Business News
  • Jan. 13, 2026, 13:02 UTC
  • 7
  • 1 comments

Natera - Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling

Market reaction Comment Full text

Alto Neuroscience Inc. (ANRO)

  • Business News
  • Jan. 13, 2026, 13:01 UTC
  • 10
  • 1 comments

Alto Neuroscience, Inc. - Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology

Market reaction Comment Full text

Omnicell Inc (OMCL)

  • Business News
  • Jan. 13, 2026, 13:01 UTC
  • 9
  • 1 comments

Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

Market reaction Comment Full text

Pacira BioSciences Inc (PCRX)

  • Business News
  • Jan. 13, 2026, 13:00 UTC
  • 4
  • 1 comments

Pacira Announces Agreement with LG Chem to Make EXPAREL® Available in Select Asian-Pacific Markets

Market reaction Comment Full text

CytoMed Therapeutics Ltd (GDTC)

  • Business News
  • Jan. 13, 2026, 13:00 UTC
  • 12
  • 1 comments

CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital

Market reaction Comment Full text

Johnson & Johnson (JNJ)

  • Business News
  • Jan. 13, 2026, 13:00 UTC
  • 10
  • 1 comments

Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting

Market reaction Comment Full text

Evaxion Biotech A/S (EVAX)

  • Business News
  • Jan. 13, 2026, 13:00 UTC
  • 12
  • 1 comments

Evaxion expands AI-Immunology™ platform into autoimmune diseases

Market reaction Comment Full text

Ginkgo Bioworks Holdings Inc. (DNA)

  • Business News
  • Jan. 13, 2026, 13:00 UTC
  • 11
  • 1 comments

Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Cassava Sciences Inc. (SAVAW)

  • Business News
  • Jan. 13, 2026, 13:00 UTC
  • 8
  • 1 comments

Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease

Market reaction Comment Full text
  • Previous
  • 67
  • 68
  • 69
  • 70
  • 71
  • Next

Search

News categories

  • Technical Exchange News(10863)
  • Event(2227)
  • SEC News(187932)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124387)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin